Background We have shown that chronic administration of the nitric oxide (NO) precursor L-arginine normalizes NOdependent vasodilation and markedly inhibits atherogenesis in a hypercholesterolemic rabbit model. We hypothesized that this antiatherogenic effect is due to modulation of endothelial adhesiveness by endothelium-derived NO.
Enhanced Endothelial Adhesiveness in Hypercholesterolemia Is
Attenuated by L-Arginine T he earliest observable abnormality of the vessel wall in hypercholesterolemic animals is enhanced monocyte adherence to the endothelium,' which occurs within 1 week of a high-cholesterol diet. This event is thought to be mediated by the surface expression of endothelial adhesion molecules and chemotactic proteins induced by hypercholesterolemia. Another endothelial alteration that occurs in parallel is a reduced activity of endothelium-derived relaxing factor (EDRP2-7). This abnormality is observed very early after the initiation of a high-cholesterol diet, well before any structural changes in the vessel wall.2 Indeed, the adverse effects of low-density lipoprotein (LDL) cholesterol on EDRF activity occur within minutes. When isolated vascular rings from normal animals are exposed to LDL cholesterol in concentrations approximating those in hypercholesterolemic individuals, endothelium-dependent relaxation is markedly inhibited after 30 minutes.3 This property of LDL cholesterol is probably dependent on its oxidation or modification and is not shared by highdensity lipoprotein (HDL) cholesterol. [4] [5] EDRF is now known to be nitric oxide (NO) or a related compound derived from metabolism of L-arginine. 8, 9 NO not only is a potent vasodilator but also inhibits leukocyte-endothelial cell interaction,'0-14 platelet adherence and aggregation, '5,6 and vascular smooth muscle cell proliferation.'7 Because these are critical processes in atherogenesis, the reduction in NO activity induced by hypercholesterolemia may promote atherogenesis. Conversely, an enhancement of NO synthesis may inhibit atherogenesis. We and others have shown that acute administration of the NO precursor L-arginine to hypercholesterolemic animals or humans normalizes NO-dependent vasodilation.'8-2' More recently, we showed that chronic dietary supplementation with L-arginine restores NO-dependent vasodilatation in hypercholesterolemic rabbits and that this improvement in NO activity is associated with a striking antiatherogenic effect. 22 In the present study, we test the hypothesis that the antiatherogenic effect of dietary arginine is mediated by endothelium-derived NO, which inhibits monocyte-endothelial cell interaction. chow (Cont, n=7), rabbit chow enriched with 1% cholesterol (Chol, n=7) (ICN Biomedical, Cleveland, Ohio), or 1% cholesterol chow supplemented with 2.25% L-arginine HCQ in the drinking water (Arg, n=7) ad libitum throughout the course of the study. Supplementation with 2.25% L-arginine HCQ (Sigma Chemical Co) in the drinking water results in a sixfold enrichment of dietary arginine (based on the daily average water and food intake of the animals) and results in a twofold increase in plasma free arginine levels.22 In a second series of studies designed to further explore the role of endogenous NO on monocyte-endothelial cell interaction, another group of animals was pair fed, receiving a normal rabbit diet supplemented with either vehicle control (n=5) or the NO synthase antagonist nitro-L-arginine (L-NA, 10 mg/100 mL; n=5) administered in the drinking water ad libitum throughout the course of the study (for an average daily dose of 13.5 mg * kg`-d-l). In a third series of experiments, animals received a normal diet and either vehicle (n=4), L-NA (13.5 mg* kg`. d-'; n=4), or L-NA and hydralazine (n=4) added to the drinking water for 2 weeks. At this dose, hydralazine (5 mg* kg`' d-'; Schein Pharmaceutical, Inc) reversed the increase in blood pressure induced by L-NA. In a fourth series of studies, after 2 weeks of treatment, thoracic aortas were harvested from Cont (n=3), Arg (n=3), Chol (n=3), and L-NA (n=4) animals for measurement of nitrogen oxides as described below.
One day before they were killed (after 2 weeks of dietary intervention), animals were lightly sedated with 3 mg subcutaneous injection of acepromazine maleate solution (Ayerst Laboratories), and the central ear artery was cannulated for measurement of intra-arterial blood pressure, followed by collection of blood samples in EDTA. Total plasma cholesterol levels as well as HDL were enzymatically measured by a spectrophotometric assay (Sigma). Aliquots of plasma were deproteinized with 2% sulfosalicylic acid and analyzed for free arginine by use of an automated amino acid analyzer ( Nevertheless, to confirm the results using WEHI 78/24 cells, in some studies we performed binding studies in parallel using normal rabbit mononuclear cells isolated from fresh whole blood of control rabbits before they were killed. Rabbits were prepared and killed as outlined below. Whole blood (40 mL) was retrieved by cardiac puncture in sodium citrate (10:1 vol/vol) and heparin (10 U/mL). Anticoagulated blood was centrifuged at 400g for 10 Groups of four to six animals (including at least one control animal) were injected intravenously with the thrombin inhibitor D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone (PPACK, 100 ng/kg) to limit platelet interference with the mononuclear cell binding studies (in preliminary studies PPACK had no effect on mononuclear cell binding to endothelium isolated from control or hypercholesterolemic rabbits). Rabbits were killed by intravenous injection of sodium pentobarbitol (Abbott Laboratories) (35 mg/kg). Thoracic aortas were removed and placed in cold, oxygenated phosphate-buffered saline. After the adventitia was removed, a 15-mm segment of thoracic aorta was excised from a point immediately distal to the left subclavian artery. The segments were then carefully opened longitudinally and placed into 35- 
Measurement of Nitrogen Oxide Release
In some experiments, the aortic segments were prepared as described above and incubated with 2 mL HBSS medium containing calcium ionophore (1 ,umol/L; Sigma) and L-arginine (100 ,umol/L; Sigma). At selected time points (0, 30, 60, and 120 minutes), samples of the medium (100 ,uL) were collected for measurement of nitrogen oxides (NO and oneelectron oxidation products of NO). Nitrogen oxides (NO1)
were measured with a commercially available chemiluminescence apparatus (model 2108, Dasibi) after reduction of the samples in boiling acidic vanadium (III) at 98"C.2324 Boiling acidic vanadium quantitatively reduces NO2-and N03-to NO, which is quantified by the chemiluminescence detector after reaction with ozone. Signals from the detector were analyzed by a computerized integrator and recorded as areas under the curve. Standard curves for NO2/N03 were linear over the range of 100 pmol to 5 nmol. Table 1) . Analysis of amino acid levels in blood samples drawn demonstrated that the 1% cholesterol diet had no effect on plasma arginine; supplementation with L-arginine in the drinking water produced a significant twofold increase in free arginine levels (P<.01). In the animals receiving the 1% cholesterol diet, no difference was observed in mean arterial blood pressure compared with control animals (Table 1) . However, administration of the NO synthase antagonist L-NA (10 mg/100 mL in drinking water) elevated mean arterial blood pressure after 2 weeks. In those animals simultaneously treated with hydralazine (5 mg * kg`-d-1), blood pressure was maintained at normal levels.
Monocytoid Cell Adhesion to Rabbit

Aortic Endothelium
Exposure of WEHI 78/24 cells to normal rabbit aortic endothelium results in a minimal cell binding in this ex vivo adhesion assay. However, when WEHI 78/24 cells were incubated with aortic endothelium from hypercholesterolemic animals (Chol, n=7), cell binding was enhanced threefold compared with Cont (n=7). Fig 2) . Similar results were achieved when adhesion assays were performed in parallel with mononuclear cells that were freshly isolated from Cont animals (n=2) in each of the three groups (data not shown).
Effect of Chronic NO Synthase Inhibition on Endothelial Adhesiveness
To further investigate the role of endothelium-derived NO in modulating endothelial cell-monocyte interaction, an additional series of binding studies was performed using thoracic aorta from animals that received regular chow supplemented with vehicle (n=5) or the NO synthase inhibitor L-NA (n=5). 78/24 cells was markedly increased when they were incubated with aortic endothelium from L-NA animals compared with control endothelium (Fig 3) . This effect could not be attributed to hypertension caused by L-NA, since concomitant administration of hydralazine normalized blood pressure but did not reverse the augmentation of cell binding induced by L-NA (Fig 4) . Fig 5) . At 120 minutes, NO, levels were significantly lower in conditioned medium from the L-NA group in comparison with the other groups (Fig 5) . Effect of L-Arginine on the In Vitro Generation of Superoxide Radical Superoxide anion was generated by the addition of xanthine oxidase to xanthine, and the reduction of cytochrome c was monitored by absorbance at 550 nm. L-Arginine (0.1 to 10.0 mmol/L) had no effect on the concentration of superoxide anion generated. By contrast, SOD effectively scavenged the superoxide anion (P<.01, Control versus SOD condition; n=5 in each group; Table 2 ). incubation with copper sulfate. Neither L-arginine nor urea had any effect on the oxidation of human LDL cholesterol, whereas the antioxidant BHT significantly inhibited the formation of TBARS (P<.01, Control versus BHT condition; n=5 in each group; Table 2 ).
Discussion
The salient findings of this investigation are that (1) the endothelium of thoracic aorta from hypercholesterolemic rabbits manifests greater adhesiveness for monocytoid cells; (2) this increase in endothelial adhesiveness is attenuated in hypercholesterolemic animals treated chronically with the NO precursor L-arginine; (3) endothelial adhesiveness is increased in vessels from normocholesterolemic animals treated with the NO synthase antagonist L-NA; (4) this effect of NO synthase antagonism is not reversed by administration of hydralazine in doses sufficient to normalize blood pressure; and (5) Mononuclear cell adherence to the endothelium and subendothelial diapedesis and migration occur within a week after the initiation of a high-cholesterol diet in primates, leading to the development of intimal lesions that contain subendothelial macrophage-derived foam cells interspersed with small numbers of non-lipid-filled macrophages and T lymphocytes.28,29 A variety of in vitro models have been developed to investigate the mechanisms that initiate this monocyte-endothelial cell interaction. Monocytes isolated from patients with combined hypercholesterolemia/hypertriglyceridemia adhere to cultured human umbilical vein endothelial cells (HUVECs) to a greater degree than those from healthy subjects. 30 Similarly, when HUVECs are incubated with plasma from cholesterol-fed rabbits31 or with minimally modified or copper-oxidized LDL,3233 they bind normal monocytes to a greater degree. This increased adhesion induced by treatment with modified LDL cholesterol is selective for monocytes in that neutrophil binding is unaffected. 31 The endothelial alteration or dysfunction that precipitates monocyte binding is not well defined. It seems likely that the induced expression of endothelial adhesion molecules and chemotactic proteins plays a major role.34 35 We propose that endothelium-derived NO modulates the expression of these adhesion molecules and/or chemotactic proteins. The first evidence to support this notion came from the work of Bath and colleagues.'2 These investigators found that exogenous endothelial dysfunctions observed in hypercholesterolemic animals and humans is reduced NO-dependent vasodilation; this abnormality occurs before the onset of observable structural changes in the vessel wall.37, 38 We propose that a reduced activity of NO in the vessel wall facilitates monocyte-endothelial cell interaction in hypercholesterolemia.
In the present investigation, the binding of monocytoid WEHI 78/24 cells (as well as freshly isolated rabbit mononuclear cells) to the endothelium of vascular segments from hypercholesterolemic animals was increased threefold compared with vascular segments from control animals. The enhanced adhesiveness of the aortic endothelium from hypercholesterolemic animals was significantly reduced by dietary arginine supplementation (Fig 2) . Conversely, when the synthesis of NO was chronically inhibited in normocholesterolemic animals by L-NA, monocytoid-endothelial cell interaction was enhanced (Fig 4) . This effect of L-NA cannot be explained by the hypertension that it induced because concomitant administration of hydralazine (which restored normal blood pressure) had no significant effect on the enhancement by L-NA of endothelial adhesiveness. These alterations in endothelial adhesiveness induced by the NO precursor L-arginine as well as the NO synthase inhibitor L-NA are paralleled by changes in the endothelial elaboration of NOQ. Taken together, these observations support the hypothesis that chronic endogenous NO modulates the affinity of endothelial cells for monocytes.
Other paracrine factors produced by the endothelium may be involved. The generation of superoxide anion by the endothelium is accelerated in hypercholesterolemia and is a major factor in the initiation and maintenance of a number of atherogenic processes.22,39 After 1 month of a 1% cholesterol diet, rabbit thoracic aortas produce threefold more superoxide anion than normal vessels; this increase in the generation of superoxide anion is largely due to the increased activity of endothelial xanthine oxidase.40 Antioxidants scavenge superoxide anion, enhance endothelium-dependent relaxation, and reduce lesion formation.39'41 Adhesion of leukocytes in vivo, induced by an infusion of oxidized LDL, is significantly inhibited by infusion of SOD or by heparininduced release of extracellular SOD from the endothelium.42 Therefore, it is possible that arginine improves NO activity and decreases monocyte adhesion by acting as an antioxidant. However, our biochemical studies reveal that arginine lacks direct antioxidant properties. Although these studies suggest that the antiadhesive effects of L-arginine are not mediated by a direct antioxidant effect, they do not exclude the possibility that a metabolite of arginine (ie, NO) may interfere with the elaboration of superoxide anion. Removal of the endothelium increases the elaboration of superoxide anion in the thoracic aorta of normolipidemic rabbits.40 Moreover, NO may reduce the oxidative modification of LDL by macrophages. 43 In that recent study, the investigators discovered that the oxidation of LDL cholesterol by macrophages was inversely proportional to their generation of NO. 43 The inhibition by NO of LDL oxidation may be due to a direct inhibitory effect on enzyme systems that generate oxygen-derived free radicals, such as NADPH oxygenase.44 It is therefore possible that the ability of NO to modulate endothelial adhesiveness is conferred by its activity against superoxide anion.
To conclude, we have used an ex vivo model of mononuclear cell binding to study the increase in endothelial adhesiveness induced by hypercholesterolemia. We show for the first time that endothelial adhesiveness is attenuated by oral administration of the NO precursor L-arginine. Conversely, inhibition of NO synthase activity by oral administration of L-NA strikingly increases endothelial affinity for monocytoid cells in vitro.
These alterations in endothelial adhesiveness are paralleled by reciprocal changes in the release of NO. by the vessel wall. The data are consistent with the hypothesis that NO is an endogenous antiatherogenic molecule.
